Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64news2022-04-30T19:09:09+00:00April 30th, 2022|The New York Times|
Lawmakers Dismiss McKinsey’s Apology on Opioid Crisis as ‘Empty’news2022-04-27T22:34:40+00:00April 27th, 2022|The New York Times|
F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Oldernews2022-03-29T23:44:53+00:00March 29th, 2022|The New York Times|
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuitsnews2022-02-25T14:12:55+00:00February 25th, 2022|The New York Times|
J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Neednews2022-02-08T16:04:03+00:00February 8th, 2022|The New York Times|
Tribes Reach $590 Million Opioid Settlement With Johnson & Johnsonnews2022-02-01T22:52:05+00:00February 1st, 2022|The New York Times|
Teva Pharmaceuticals Found Liable in Landmark Opioid Trialnews2021-12-30T23:06:33+00:00December 30th, 2021|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
Beneath a Covid Vaccine Debacle, 30 Years of Government Culpabilitynews2021-12-23T10:00:26+00:00December 23rd, 2021|The New York Times|
South African Company Nears License to Sell J. & J. Covid Shot Across Africanews2021-11-30T21:07:51+00:00November 30th, 2021|The New York Times|
